Cone Lawrence A, Sontz Eric M, Wilson Joseph W, Mitruka S N
Department of Medicine, Section of Infectious Diseases, Eisenhower Medical Center, Rancho Mirage, CA 92270, USA.
Int J Infect Dis. 2005 Nov;9(6):335-9. doi: 10.1016/j.ijid.2004.08.004. Epub 2005 Aug 8.
Newer microbiologic methods to determine the species of coagulase-negative staphylococci (CoNS) have evolved which have shown that most endocarditis due to CoNS is caused by Staphylococcus epidermidis, and far fewer by Staphylococcus warneri and Staphylococcus lugdunensis.
The recent opportunity to successfully treat a patient with methicillin-resistant Staphylococcus capitis endocarditis secondary to an infected transvenous pacemaker led to a review of the literature relating to S. capitis endocarditis.
Thirteen previously recorded patients were identified. Twelve (86%) patients were male. Ten had endocarditis associated with a native valve, two with prosthetic valves and one with a transvenous pacemaker. Mortality was low in all 14 cases (including this case report) with only two deaths; one in a patient with a native valve and the other with a prosthetic valve. Four of the isolates were methicillin resistant but sensitive to vancomycin, which was used in the treatment of eight patients. Those patients with prosthetic cardiac devices appear to do better when the devices are surgically removed.
CoNS as a cause of endocarditis appears to be increasing and the current ability to determine the species of these organisms should elicit the epidemiology, clinical characteristics and biomolecular mechanisms involved in the induction of valvular disease.
用于确定凝固酶阴性葡萄球菌(CoNS)菌种的更新的微生物学方法已经出现,这些方法表明,大多数由CoNS引起的心内膜炎是由表皮葡萄球菌引起的,而由华纳葡萄球菌和路邓葡萄球菌引起的则少得多。
最近有机会成功治疗一名因感染性经静脉起搏器继发耐甲氧西林头状葡萄球菌心内膜炎的患者,这促使我们对与头状葡萄球菌心内膜炎相关的文献进行了回顾。
确定了13例先前记录的患者。12例(86%)为男性。10例患有与天然瓣膜相关的心内膜炎,2例患有人工瓣膜心内膜炎,1例患有经静脉起搏器相关的心内膜炎。在所有14例病例(包括本病例报告)中死亡率较低,仅有2例死亡;1例为天然瓣膜患者,另1例为人工瓣膜患者。4株分离株对甲氧西林耐药,但对万古霉素敏感,8例患者使用了万古霉素进行治疗。当手术移除人工心脏装置时,患有该装置的心内膜炎患者似乎预后更好。
CoNS作为心内膜炎的病因似乎在增加,目前确定这些微生物菌种的能力应该能够揭示瓣膜疾病诱发过程中的流行病学、临床特征和生物分子机制。